S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study. (October 2021) - Janssen, Harry; Heo, Jeong; Fournier, Claire; Ahn, Sang Hoon; Coffin, Carla S.; 黃, 怡翔; Hui, Aric Josun; Elkhashab, Magdy; Jafri, Syed-Mohammed; Mo, Shuyuan; Winans, Jake; Flaherty, John; et al.